Genomics and COVID-19 Vaccine Adverse Events

RecruitingOBSERVATIONAL

Enrollment

6,325

Participants

Timeline

Start Date

June 24, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Vaccine Adverse Reaction

Interventions

BIOLOGICAL

COVID-19 vaccines

Any licensing COVID-19 vaccine platform

Trial Locations (1)

RECRUITING

British Columbia Children's Hospital Research Institute, Vancouver

All Listed Sponsors

collaborator

Centers for Disease Control and Prevention

FED

lead

University of British Columbia

OTHER